Golub LM - Search Results

1

Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.

Gu Y, Lee HM, Golub LM, Sorsa T, Konttinen YT, Simon SR. Gu Y, et al. Among authors: golub lm. Ann Med. 2005;37(6):450-60. doi: 10.1080/07853890500300386. Ann Med. 2005. PMID: 16203617 Free article.

2

Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.

Kocer SS, Walker SG, Zerler B, Golub LM, Simon SR. Kocer SS, et al. Among authors: golub lm. Infect Immun. 2005 Nov;73(11):7548-57. doi: 10.1128/IAI.73.11.7548-7557.2005. Infect Immun. 2005. PMID: 16239558 Free PMC article.

3

Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdown.

Gu Y, Lee HM, Sorsa T, Simon SR, Golub LM. Gu Y, et al. Among authors: golub lm. FEMS Immunol Med Microbiol. 2010 Mar;58(2):218-25. doi: 10.1111/j.1574-695X.2009.00625.x. Epub 2009 Nov 10. FEMS Immunol Med Microbiol. 2010. PMID: 19909341 Free article.

4

Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase.

Gu Y, Lee HM, Simon SR, Golub LM. Gu Y, et al. Among authors: golub lm. Pharmacol Res. 2011 Dec;64(6):595-601. doi: 10.1016/j.phrs.2011.05.011. Epub 2011 May 31. Pharmacol Res. 2011. PMID: 21651982 Review.

5

Design, synthesis and biological activity of new polyenolic inhibitors of matrix metalloproteinases: a focus on chemically-modified curcumins.

Zhang Y, Gu Y, Lee HM, Hambardjieva E, Vranková K, Golub LM, Johnson F. Zhang Y, et al. Among authors: golub lm. Curr Med Chem. 2012;19(25):4348-58. doi: 10.2174/092986712802884295. Curr Med Chem. 2012. PMID: 22830350

6

A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats.

Golub LM, Ramamurthy NS, Llavaneras A, Ryan ME, Lee HM, Liu Y, Bain S, Sorsa T. Golub LM, et al. Ann N Y Acad Sci. 1999 Jun 30;878:290-310. doi: 10.1111/j.1749-6632.1999.tb07691.x. Ann N Y Acad Sci. 1999. PMID: 10415737

7

Inhibition of tumor cell invasiveness by chemically modified tetracyclines.

Gu Y, Lee HM, Roemer EJ, Musacchia L, Golub LM, Simon SR. Gu Y, et al. Among authors: golub lm. Curr Med Chem. 2001 Feb;8(3):261-70. doi: 10.2174/0929867013373642. Curr Med Chem. 2001. PMID: 11172681

8

A chemically modified tetracycline (CMT-3) is a new antifungal agent.

Liu Y, Ryan ME, Lee HM, Simon S, Tortora G, Lauzon C, Leung MK, Golub LM. Liu Y, et al. Among authors: golub lm. Antimicrob Agents Chemother. 2002 May;46(5):1447-54. doi: 10.1128/AAC.46.5.1447-1454.2002. Antimicrob Agents Chemother. 2002. PMID: 11959581 Free PMC article.

9

Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3.

Liu Y, Tortora G, Ryan ME, Lee HM, Golub LM. Liu Y, et al. Among authors: golub lm. Antimicrob Agents Chemother. 2002 May;46(5):1455-61. doi: 10.1128/AAC.46.5.1455-1461.2002. Antimicrob Agents Chemother. 2002. PMID: 11959582 Free PMC article.

10

Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.

Lee HM, Ciancio SG, Tüter G, Ryan ME, Komaroff E, Golub LM. Lee HM, et al. Among authors: golub lm. J Periodontol. 2004 Mar;75(3):453-63. doi: 10.1902/jop.2004.75.3.453. J Periodontol. 2004. PMID: 15088884 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters